Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.150
+0.005 (3.45%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $11.13 million as of July 26, 2024. Its market cap has decreased by -81.20% in one year.
Market Cap
11.13M
Enterprise Value
-34.86M
1-Year Change
-81.20%
Ranking
n/a
Category
Stock Price
$0.15
Market Cap Chart
Since December 1, 1998, Enzon Pharmaceuticals's market cap has decreased from $405.00M to $11.13M, a decrease of -97.25%. That is a compound annual growth rate of -18.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2016 | 20.30M | -32.33% |
| Dec 31, 2015 | 30.00M | -37.63% |
| Dec 31, 2014 | 48.10M | -5.87% |
| Dec 31, 2013 | 51.10M | -74.03% |
| Dec 31, 2012 | 196.80M | -39.17% |
| Dec 30, 2011 | 323.50M | -55.48% |
| Dec 31, 2010 | 726.60M | 51.82% |
| Dec 31, 2009 | 478.60M | 82.60% |
| Dec 31, 2008 | 262.10M | -37.73% |
| Dec 31, 2007 | 420.90M | 12.66% |
| Dec 29, 2006 | 373.60M | 13.83% |
| Dec 30, 2005 | 328.20M | -45.37% |
| Dec 31, 2004 | 600.80M | 15.34% |
| Dec 31, 2003 | 520.90M | -27.55% |
| Dec 31, 2002 | 719.00M | -70.12% |
| Dec 31, 2001 | 2.41B | -6.51% |
| Dec 29, 2000 | 2.57B | 61.21% |
| Dec 31, 1999 | 1.60B | 238.74% |
| Dec 31, 1998 | 471.40M | 16.40% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 780.46B |
| Novo Nordisk | 581.89B |
| UnitedHealth Group | 515.12B |
| Johnson & Johnson | 384.20B |
| AbbVie | 321.69B |
| Merck & Co. | 318.75B |
| AstraZeneca | 243.45B |
| Thermo Fisher | 226.93B |